Impact of breast cancer care pathways and related symptoms on the return-to-work process: results from a population-based French cohort study (CONSTANCES)

Table 1 Sociodemographic characteristics at diagnosis, BC treatments and drug deliveries in the group of active women at BC diagnosis (from the CONSTANCES cohort, 2012–2018; n = 626)

	N	%
Sociodemographic characteristics
Age (years) median(IQR)	49.1	44.0–54.3
Household composition
In couple without < 18-year-old children	241	38.5
In couple with < 18-year-old children	170	27.2
Single without < 18-year-old children	161	25.7
Single with < 18-year-old children	54	8.6
Household income^a
Low income	133	21.2
Middle income	253	40.4
High income	240	38.3
Education level
Primary and secondary education	248	39.6
Higher education	378	60.4
Occupational category at BC diagnosis
Intellectual professionals/managers	144	23.0
Employees/clerks	252	40.3
Intermediate profession/technicians	207	33.1
Skilled/unskilled manual workers	23	3.7
BC treatments and drug deliveries^b
Total mastectomy
No	467	74.6
Yes	159	25.4
Breast-conservative surgery
No	124	19.8
Yes	502	80.2
Axillary lymph node dissection
No	264	42.2
Yes	362	57.8
Breast reconstruction
No	530	84.7
Yes	96	15.3
Chemotherapy
No	342	54.6
Yes	284	45.4
Radiotherapy
No	346	55.3
Yes	280	44.7
Hormone therapy
No	198	31.6
Yes	428	68.4
Antidepressant/anxiolytic drug delivery
No	243	38.8
Yes	383	61.2
Antalgic drug delivery
No	229	36.6
Yes	397	63.4

BC, breast cancer; IQR, Interquartile range
^aLow income: < 1,500€ if one contributor or < 2,800€ if two or more contributors in the household; Middle income: between 1,500€ and 2,000€ if one contributor or between 2,800€ and 4,100€ if two or more contributors; High income: ≥ 2,000€ if one or ≥ 4,100€ if two or more contributors in the household
^bEach BC treatment or drug was delivered at least once within the two years after BC diagnosis (yes/no)

ISSN: 1465-542X